What You Should Know:
- In a significant step towards improving cardiovascular care, several Medicare Administrative Contractors (MACs) have granted coverage for Cleerly's AI-enabled Quantitative Coronary Topography (AI-QCT) scans.
- The decision expands access to Cleerly's potentially life-saving technology for Medicare beneficiaries at risk of heart attacks.
Expanding Access to Innovative Cardiac Care
Cleerly, a company dedicated to eradicating heart attacks, sought MAC
Read More
Heart Disease | Transforming Heart Disease through Medical Technology for Patients
Amwell Integrates with Hello Heart to Offer Digital Cardiovascular Solution
What You Should Know:
- Amwell, a digital health platform, has joined forces with Hello Heart, a pioneer in preventive heart health, to offer a comprehensive digital solution for individuals at risk of cardiovascular disease.
The partnership integrates Hello Heart's innovative program into Amwell's Converge platform, providing a seamless and accessible way for health plan members to manage their heart health.
Addressing a Critical Need
Heart disease remains the leading
Read More
WearLinq Acquires AMI Cardiac Monitoring, Raises $6.7M for FDA-Cleared 6-Lead ECG Device
What You Should Know:
- WearLinq, a leader in wearable health monitoring, announced a strategic acquisition of AMI Cardiac Monitoring, LLC, a seasoned player in ambulatory cardiac monitoring.
- The acquisition, coupled with a recent $6.7M funding round, positions WearLinq to significantly expand access to their innovative eWave 6-lead ECG monitor and revolutionize the fight against atrial fibrillation (AFib), which recently received FDA 510(k) clearance.
Tackling the
Read More
Cedars Sinai Researchers Uses AI to Analyze Regular Chest CT Scans to Predict Heart Disease Risk
What You Should Know:
- Researchers at Cedars-Sinai have developed a new method using artificial intelligence (AI) to assess cardiovascular disease risk during a routine chest computed tomography (CT) scan without contrast dye.
- The recent study published in Nature Communications, could significantly reduce the cost and invasiveness of identifying patients at risk for heart disease.
Leveraging Existing Data for Better Risk Assessment
Traditionally, CT scans with contrast
Read More
Exo® Launches FDA-Cleared AI on Exo Iris™ to Address Heart Failure
What You Should Know:
Exo® (pronounced “echo”), a medical imaging software and devices company, today announced its FDA-cleared cardiac and lung artificial intelligence (AI) applications are now available on Exo Iris™, Exo’s high-performance handheld ultrasound device. With affordable, AI-powered medical imaging in a pocket-sized device, caregivers can get to answers immediately to accelerate diagnosis and create new care pathways for heart failure patients at the point of care. As
Read More
Heart Disease: Still the Silent Killer Despite Prevention Options
Given the attention paid to the devastating impact of COVID-19, one might assume it was the leading cause of death in the US. But while the fatalities were stark – almost 1.2 million Americans died of COVID in the last 4 years – heart disease remains the largest cause of death and by a landslide. In 2021, the year with the most COVID-19 deaths (416,893), heart disease claimed 60% more lives (695,000) in the US. Perhaps more, striking, however, is that many, if most, of these deaths, were
Read More
Ventricle Health Secures $8M to Accelerate Value-Based Home Care Model for Heart Failure
What You Should Know:
- Ventricle Health - a new national, virtual cardiology clinical reimagining cardiac care delivery - raises $8M in seed funding led by RA Capital and Waterline Ventures.
- This company will used the seed funding to expand Ventricle Health’s heart failure management therapeutic model in collaboration with value-based care provider groups and payers, which can reduce the overall average annual cost of heart failure care by at least 30-50%.
Virtual
Read More
iRhythm Launches Wearable ECG Heart Monitor
What You Should Know:
iRhythm Technologies, Inc. today announced the U.S. launch of its next-generation Zio® monitor and enhanced Zio® long-term continuous monitoring (LTCM) service.Zio monitor is iRhythm’s smallest, lightest and thinnest cardiac monitor, enhancing the cardiac monitoring experience for patients and healthcare providers together with new service enhancements. The new Zio monitor is a prescription-only ECG monitor, which is an integral part of the Zio LTCM service.
Read More
Robotics + Heart Valve Startup, Capstan Medical Raises $31.4M
What You Should Know:
Today, Santa Cruz-based Capstan Medical, a developer of minimally invasive technology to address heart valve disease, announced $31.4M Series B investment round led by Eclipse.The Series B round included participation from Intuitive Ventures and Puma Venture Capital, a new firm founded by Amit Hazan, a veteran Wall Street medical technology analyst, and Dr. Vipul Patel, a renowned robotic surgeon who has performed more robotic procedures than any other
Read More
Geisinger Taps Bodyport to Launch Remote Heart Failure Monitoring Program
What You Should Know:
Geisinger, an integrated health care delivery and coverage organization serving members in central and northeastern Pennsylvania forms a strategic collaboration with Bodyport, a virtual care company focused on heart failure to launch remote heart failure monitoring program. Together, Geisinger and Bodypart will develop and implement a fluid-guided care pathway for heart failure. The pathway will augment Geisinger’s existing remote heart failure management
Read More
